A week after the temporary end of a month-long partial government shutdown, the stakes are high for FDA as lawmakers and the White House resume talks on a possible deal to fund the government when the short-term spending bill ends Feb. 15. FDA experts are anxiously waiting to see whether Congress passes an appropriations bill that hikes FDA funding for the rest of fiscal 2019, passes a continuing resolution that keeps the agency at 2018 levels or moves to another...